AgomAb Therapeutics N.V. American Depositary Shares
Market Cap
$342.75K
P/E Ratio
-10.23
EPS
$-1.34
Dividend Yield
0.00%
52-Week Range
$12.66 — $17.45
Volume
147.53K
Avg Volume
230.80K
Beta
0.00
P/E (TTM)
-10.23
Forward P/E
—
PEG Ratio
-0.09
P/S (TTM)
0.00
P/B (TTM)
0.00
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.00%
ROA (TTM)
0.00%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
0.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.00
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
25.00K
Float
25.00K
Free Float %
99.98%
Sector
Healthcare
Industry
Biotechnology
Country
BE
Exchange
NASDAQ
IPO Date
2024-05-29
Employees
57
CEO
Tim Knotnerus
Index Membership
—
Website
https://agomab.com
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $342.75K, a P/E ratio of -10.23, AGMB is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AGMB against other stocks using dozens of fundamental and technical filters.
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) has a trailing twelve-month (TTM) P/E ratio of -10.23. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) has a market capitalization of $342,750, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.